Overall survival and quality of life with [177Lu]Lu-PSMA-617 plus enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer (ENZA-p): secondary outcomes from a multicentre, open-label, randomised, phase 2 trial

Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Anthony M. Joshua, Shahneen Sandhu, Andrew Nguyen, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J. Francis, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian Kirkwood, Craig Gedye, Natalie Rutherford, Aravind S. Ravi Kumar, David Pook, Shakher Ramdave, David Nadebaum, Mark Voskoboynik, Andrew Redfern, W A Macdonald, Laurence E. Krieger, Geoffrey Schembri, Wei Chua, Peter Lin, Lisa G. Horvath, Patricia Bastick, Patrick Butler, Alison Yan Zhang, Margaret McJannett, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Andrew Martin, Ian D. Davis, Martin R. Stockler, Martin R Stockler, Louise Emmett, Louise Emmett, Shalini Subramaniam, Megan Crumbaker, Anthony M. Joshua, Shahneen Sandhu, Andrew Nguyen, Andrew Weickhardt, Sze-Ting Lee, Siobhan Ng, Roslyn J. Francis, Jeffrey C. Goh, David A. Pattison, Thean Hsiang Tan, Ian D. Kirkwood, Craig Gedye, Natalie K. Rutherford, Aravind S. Ravi Kumar, David Pook, Shakher Ramdave, David P. Nadebaum, Mark Voskoboynik, Andrew D. Redfern, William Macdonald, Laurence Krieger, Geoff Schembri, Wei Chua, Peter Lin, Lisa Horvath, Patricia Bastick, Patrick Butler, Alison Yan Zhang, Margaret McJannett, Hayley Thomas, Ailsa Langford, Michael S. Hofman, Andrew J. Martin, Ian D. Davis, Martin R. Stockler, Danka Zebic, Blossom Mak, Nicole Tankard, Nisha Rana, Thomas Cusick, Jennifer Thompson, Samantha Oakes, Claire Niu, Thida Thein, Kate Ford, Nikola Ristevski, Sonia Yip, Madison Bills